The performance of DWI and ADC values with different b-values for the diagnosis and staging of endometrial carcinoma at 3T

在3T磁共振成像中,不同b值下DWI和ADC值对子宫内膜癌诊断和分期的性能研究

阅读:1

Abstract

OBJECTIVE: To evaluate the efficiency of diffusion weighted imaging (DWI), the mean apparent diffusion coefficient (ADCmean) and the minimum apparent diffusion coefficient (ADCmin) values with different b-values (800 s/mm² and 1000 s/mm²) in the diagnosis and staging of endometrial carcinoma (EC). METHODS: Preoperative DWI images of 412 patients with EC and 134 patients with benign endometrial lesions were analyzed retrospectively. The performance of DWI images, ADCmean and ADCmin values with different b-values (800 s/mm² and 1000 s/mm²) for the diagnosis and staging (deep myometrial invasion, cervical stromal invasion and lymph node metastasis) of EC was assessed by using receiver operating characteristic curve (ROC). The comparison between AUCs was performed using the DeLong test, and a P value < 0.05 was considered statistically significant. RESULTS: The area under the curves (AUCs) of DWI protocol with b = 1000 s/mm(2) for qualitative assessment of EC diagnosis and staging (0.850, 0.837, 0.906, and 0.820 for diagnosis, deep myometrial invasion, cervical stromal invasion and lymph node metastasis, respectively) were higher than those of b = 800 s/mm(2) (0.821, 0.795, 0.860 and 0.814, respectively) (all p < 0.05). The AUCs for the quantitative assessment of EC diagnosis and staging with ADCmean and ADCmin values with b = 1000 s/mm(2) were higher than those of b = 800 s/mm(2) (all p < 0.05). CONCLUSIONS: DWI images, ADCmean and ADCmin values with b = 1000 s/mm(2) had higher performance than those of b = 800 s/mm(2) in the assessment of EC diagnosis and staging. This study highlights the potential of using b = 1000 s/mm² as an optimized protocol for EC assessment in clinical practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。